Skip to content

The clinical survey of prognosis and evaluation of treatment regimen in IgA Nephropathy diagnosed in Kurume University Hospital.

The clinical survey of prognosis and evaluation of treatment regimen in IgA Nephropathy diagnosed in Kurume University Hospital. - The clinical survey of prognosis and evaluation of treatment regimen in IgA Nephropathy diagnosed in Kurume University Hospital.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000016660
Enrollment
400
Registered
2015-03-15
Start date
2014-05-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgA Nephropathy

Interventions

None listed

Sponsors

Division fo Nephrology, Department of Medicine, Kurume University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Only patients with IgA Nephropathy diagnosed by renal biopsy in our hospital.

Exclusion criteria

Exclusion criteria: Directors of the hospitals do not allow us to collect clinical data.

Design outcomes

Primary

MeasureTime frame
We checked eGFR, protein urin, microscopic hematuria, dialysis and death after 2 years and 4 years of renal biopsy, and at the end of the follow-up period.

Countries

Japan

Contacts

Public ContactMAYUKO HANAI

Department of Medicine, Kurume University School of Medicine Division fo Nephrology

nephron@med.kurume-u.ac.jp0942-35-3311(5346)

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026